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ABSTRACT 
Background & Aims: Development of strictures is a major concern for patients with 
eosinophilic esophagitis (EoE). At diagnosis, EoE can present with an inflammatory 
phenotype (characterized by whitish exudates, furrows, and edema), a stricturing phenotype 
(characterized by rings and stenosis), or a combination of these. Little is known about 
progression of stricture formation; we evaluated stricture development over time in the 
absence of treatment and investigated risk factors for stricture formation. 
 
Methods: We performed a retrospective study using the Swiss EoE Database, collecting data 
on 200 patients with symptomatic EoE (153 men; mean age at diagnosis, 39±15 y old). 
Stricture severity was graded based on the degree of difficulty associated with passing of the 
standard adult endoscope. 
 
Results: The median delay in diagnosis of EoE was 6 y (inter-quartile range, 2–12 y). With 
increasing duration of delay in diagnosis, the prevalence of fibrotic features of EoE, based on 
endoscopy, increased from 46.5% (diagnostic delay, 0–2 years) to 87.5% (diagnostic delay, 
>20 y; P=.020). Similarly, the prevalence of esophageal strictures increased with duration of 
diagnostic delay, from 17.2% (diagnostic delay, 0–2 years) to 70.8% (diagnostic delay, >20 y; 
P<.001). Diagnostic delay was the only risk factor for strictures at the time of EoE diagnosis 
(odds ratio, 1.08; 95% confidence interval, 1.040–1.122; P<.001). 
 
Conclusions: The prevalence of esophageal strictures correlates with the duration of 
untreated disease. These findings indicate the need to minimize delay in diagnosis of EoE. 
 
Keywords: esophagus, complications, inflammation, remodeling 
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INTRODUCTION 
     Eosinophilic esophagitis (EoE) has recently been defined by an expert panel as “a 
chronic, immune/antigen-mediated, esophageal disease characterized clinically by 
symptoms related to esophageal dysfunction and histologically by eosinophil-predominant 
inflammation”.[1] 
     There is evidence that EoE incidence increased over the last decades with current 
prevalence rates in the Unites States and Europe of about 1 affected individual among 2,000 
inhabitants in the pediatric as well as in the adult population.[2-6]  Adult EoE patients 
primarily suffer from dysphagia, often culminating in food impaction necessitating endoscopic 
bolus removal.[7-9] 
     The endoscopic presentation of EoE is quite variable. Recently, the endoscopic features 
of EoE have been graded by Hirano et al.[10] For the purposes of this study, characteristic 
features of EoE were classified into two categories, the inflammatory and the fibrotic group of 
EoE features. According to this classification, whitish exudates, edema and linear furrows 
represent the items of acute inflammation.[11] Normal esophageal diameter is another 
hallmark characteristic associated with the inflammatory group of endoscopic features. The 
fibrotic features of EoE are rings, strictures, and crêpe-paper esophagus. Most patients 
present with a mix of these inflammatory and fibrotic features at the time of EoE 
diagnosis.[1,12]  
     There is a lack of data evaluating stricture development over time in EoE. We know from 
natural history studies in Crohn’s disease that patients initially present with an inflammatory 
phenotype and that complications (strictures and/or fistulas) develop over time.[13,14] It is 
presently unknown whether, similar to Crohn’s disease progression, EoE is initially 
characterized by the occurrence of inflammatory features, and, as inflammation persists, 
fibrotic features, including strictures, develop over time. The lack of data on stricture 
formation in EoE may be related to the fact that EoE is diagnosed with a longer diagnostic 
delay (time period from appearance of first symptoms to diagnosis, median 5 years in EoE) 
when compared with Crohn’s disease (median 0.75 years).[7,15] During this long diagnostic 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
5 
 
delay, unbridled eosinophil-predominant inflammation is allowed to persist, such that patients 
may present with strictures at the time of diagnosis. Given the imminent risk of food bolus 
impactions, purely observational studies of untreated EoE patients are rare for reasons 
related to ethical standards.[7] Therefore, we examined the relationship between the duration 
of untreated disease, which corresponds to the diagnostic delay (time period from symptom 
onset to EoE diagnosis), and the appearance of endoscopic alterations at time of EoE 
diagnosis. 
    We aimed to examine whether the length of diagnostic delay positively correlates with the 
frequency of encountering strictures in EoE patients at the time of diagnosis. An additional 
aim of the present study was to determine the kinetics of the appearance of inflammatory 
and fibrotic endoscopic features over time. We also aimed to identify risk factors for stricture 
development. 
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METHODS 
 
Swiss EoE Database 
     We performed a retrospective analysis of the Swiss EoE database (SEED) and an 
extensive review of all patient records. The SEED has been founded in 1989 by the senior 
author (AS) and currently includes data on 783 EoE patients from all over Switzerland. The 
data are stored in the Swiss EoE Clinic located in Olten, Switzerland. Of 783 patients, 323 
patients (41.3 %) are followed-up and treated on a regular basis in the Swiss EoE Clinic by 
the senior author. In order to minimize the limitations of the retrospective design of this study, 
only data gathered in structured manner on 323 patients, who personally attended the Swiss 
EoE Clinic, were used to carry out most of the analysis. The data on the remaining 460 EoE 
patients (58.7 %), who were diagnosed externally by other gastroenterologists in 
Switzerland, were only used to examine the occurrence of strictures over time. 
     Patients, whose data were included into the SEED, had to meet the following criteria: 1) 
report the presence of symptoms of esophageal dysfunction, 2) exhibit predominant 
eosinophilic esophageal inflammation, 3) either test negative by 24-hour pH-metric study or 
have esophageal eosinophilia that did not resolve following a completion of at least a 6-week 
double-dose PPI trial. Data of patients with histologically-diagnosed eosinophilic 
gastroenteritis were not included into SEED. For the purposes of inclusion into SEED, four 
biopsies from the distal esophagus (defined as the part lying > 5 cm above the gastro-
esophageal junction) and four biopsies from the proximal esophagus were taken during each 
upper endoscopy from every patient. Between 1989 and 2007, the diagnostic criterion for 
EoE was met, if ≥ 24 eosinophils per high power field (hpf) were observed in any of the fields 
examined. From the time of publication of the first consensus recommendation (2007), the 
diagnostic criterion for EoE was met, if ≥ 15 eosinophils per high power field (hpf) were 
observed in any of the fields examined.[16] In the SEED, items pertaining to demographics, 
disease-specific characteristics, EoE family history, history of allergies, EoE-related 
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laboratory abnormalities, history of endoscopies, histologic findings, medications and 
complications, are recorded. 
     In addition, the records of all patients included in the analysis presented in this manuscript 
were reviewed under the supervision of AMS and AS, and a new database was created in 
EpiData (version 3.1, The EpiData Association, Denmark). This database incorporates a total 
of 98 items, of which 22 are related to EoE patient history and 76 related to symptoms, 
endoscopic, laboratory and histologic findings assessed and therapeutic decisions made 
during each visit. For the purposes of this study, diagnostic delay was defined as the time 
period from appearance of first symptoms to establishment of EoE diagnosis. 
     In addition to the above-mentioned criteria for SEED inclusion, patients were only 
included into this study if a complete data set consisting of the following documents was 
obtained: a standardized symptom assessment questionnaire completed during each visit, a 
record of complete laboratory work-up of samples obtained on the day of patient interview 
and endoscopy, an endoscopy report containing a structured description and photographic 
documentation of the endoscopic findings and a histology report on the biopsies taken from 
the proximal and distal esophagus. 
 
Description of Endoscopic Findings 
     Since 1989, the following endoscopic signs were consistently described: edema (defined 
as reduced vascular pattern), white exudates (defined as white spots of the esophageal 
surface), furrows (defined as vertical lines), rings, crêpe-paper esophagus (lacerations), and 
strictures. The endoscopic features described in Swiss EoE Clinic visit records were identical 
to those that were used by Hirano et al. for a novel grading system for endoscopic 
esophageal features of EoE.[10] 
     For the purposes of this study, strictures were defined as narrowing of the esophageal 
diameter, irrespective of the length of the stricture. Stricture severity was classified as 
described elsewhere.[17] Briefly, a stricture was classified as low-grade if it could be passed 
with a standard endoscope (measured 9 mm in outer diameter) with some resistance, often 
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inducing lacerations (also described as crêpe-paper esophagus). A stricture was classified 
as intermediate-grade if it could not be passed with a 9-mm outer diameter endoscope, but 
could be passed with a 6-mm outer diameter endoscope. A stricture was classified as high-
grade if it could not be passed with a 6-mm outer diameter endoscope. If multiple strictures 
were found, the diameter of the narrowest stricture was reported. The length and location of 
strictures were recorded. Stricturing rings were assigned a length of 0.5 cm. 
 
Histologic Analyses 
     The biopsies of all SEED patients followed up at the Swiss EoE Clinic were evaluated by 
CB. For the purposes of histologic examination, 4-µm sections were cut from the paraffin 
blocks and stained with H&E, van Gieson, Alcian blue and Periodic acid-Schiff stain. All 
histologic examinations were performed using a standard pathology microscope (Zeiss 
Axiophot, Plan-Neofluar 40, ocular magnification 10 ×, area of microscopic field 0.260 mm2). 
At least 10 sections of each esophageal biopsy specimen were surveyed, and the 
eosinophils in the most densely infiltrated area were counted (peak eosinophil count). The 
extent of subepithelial fibrosis was visualized using the van Gieson stain and 
semiquantiatively graded as either absent, mild/moderate, or severe. 
 
Ethics 
     The study was approved by the local ethics committee. Prior to inclusion into the SEED, a 
written informed consent was obtained from all patients. 
 
Statistical Analysis 
     Data from EpiData were imported into a statistical package program (STATA® version 12, 
College Station, Texas, USA). Data distribution was analyzed using Normal-QQ-Plots. 
Results of quantitative data are presented as either mean ± SD and range (for parametric 
data) or median plus interquartile range (IQR) (for non-parametric data). Categorical data 
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were summarized as the percentage of the group total. Differences in quantitative data 
distributions between the groups were assessed by the Student’s t-test (for parametric data) 
and by the Wilcoxon rank-sum test (for non-parametric data). Univariate logistic regression 
modeling was performed to identify risk factors for the outcome “presence of stricture(s) at 
the time of EoE diagnosis”. As dependent variables for the outcome, the following items were 
evaluated: gender (coded as “male” and “female”, binary variable), allergies (coded as 
“present” and “absent”, binary variable), diagnostic delay (in years, continuous variable), age 
at EoE symptom onset (in years, continuous variable), EoE family history (coded as “present” 
and “absent”, binary variable), blood eosinophilia at EoE diagnosis (defined as > 0.3 G/L, 
coded as “present” and “absent”, binary variable), elevated levels of IgE (defined as IgE level 
of > 100 kU/L, coded as “present” and “absent”, binary variable), and severe histologic 
activity (defined as peak eosinophil count of > 100 per hpf, coded as “present” and “absent”, 
binary variable). For the purposes of this study, a p-value of < 0.05 was considered 
statistically significant. 
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RESULTS 
 
Patient Characteristics 
     The flow chart of the study population is shown in Supplementary Figure 1. Of 783 
patients included into SEED, 323 were diagnosed by the senior author according to 
standardized protocols for assessment of clinical, endoscopic, histologic, and laboratory 
disease activity. Data on 123 patients were excluded due to either incomplete or missing 
information (records of 41, 37, 26, and 19 patients were missing data on the endoscopic 
features of EoE, symptom severity, laboratory workup, and histology, respectively). The 
remaining 200 EoE patients had complete datasets on clinical, endoscopic, histologic, and 
laboratory disease activity and were included for further analysis. The demographic and 
disease-specific characteristics of the patients included in this study are presented in Table 
1. Of 200 patients, 153 patients were male (76.5 %) with median age at diagnosis of 39 
years (IQR 28 - 50). Dysphagia was the leading symptom exhibited by 189 EoE patients 
(94.5 %), followed by chest pain affecting 71 patients (35.5 %). Allergies were identified in 
132 patients (66.0 %). An endoscopic bolus removal was performed in 56 (28.0 %) patients; 
28 patients underwent this procedure prior to and 28 at the time of EoE diagnosis. Median 
diagnostic delay was 6 years (IQR 2 - 12). Sixty patients (30.0 %) had EoE symptom onset 
between 0 and ≤ 20 years of age, whereas 140 patients had symptom onset at > 20 years of 
age. Twenty-two patients (11.0 %) were diagnosed with EoE between 10 and ≤ 20 years of 
age. Diagnostic delay was longest in the young patient population (≤ 20 years of age) and 
decreased with increasing age (Figure 1). 
     Of 783 patients included into SEED, 460 EoE patients were diagnosed externally by other 
gastroenterologists in Switzerland. Due to the limited and non-standardized data available for 
this group of patients, only data for the occurrence of strictures over time, which was 
available for 359 patients, was used in this manuscript. Of these 349 patients, 277 (79.4%) 
were male with median age at EoE diagnosis of 38 years (IQR 26-53 years). Dysphagia was 
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the predominant symptom in 336 patients (96.3%). Median diagnostic delay was 5 years 
(IQR 2-10). 
 
Endoscopic, Histologic, and Laboratory Characteristics at EoE Diagnosis 
     The key endoscopic, histologic, and laboratory findings at the time of EoE diagnosis are 
illustrated in Table 2. Strictures were found in 75 patients (37.5 %). Further details on the 
number and other characteristics of esophageal strictures are provided in Table 3. Patients 
had a median of 1 stricture (IQR 1 - 1, range 1 - 3). 
     Features of active inflammation (edema, furrows, and whitish exudates) were found in 
159 patients (79.5 %) and features of fibrotic activity (strictures, rings and crêpe-paper 
esophagus) were detected in 126 patients (63.0 %) at EoE diagnosis. An endoscopic dilation 
of stricture(s) was performed in 27 patients (13.5 %). No perforation was observed in dilated 
patients. Fifty eight patients (29.0 %) had peripheral blood eosinophilia (> 0.35 G/L), and 124 
patients (62.0 %) had elevated IgE levels (> 100 kU/L). 
 
Evolution of Endoscopic Features Over Time 
     The analysis of the types of the endoscopic features present at the time of EoE diagnosis 
stratified according to the length of diagnostic delay is shown in Figure 2. In this report, 
whitish exudates, furrows and/or edema were considered as inflammatory features, whereas 
corrugated rings, strictures and/or crêpe paper esophagus were considered as fibrotic 
features. Figure 2 shows that the prevalence of fibrotic endoscopic features at the time of 
EoE diagnosis either alone or in combination with inflammatory features increased with 
increasing duration of diagnostic delay from 46.5 % (diagnostic delay 0 - 2 years) to 87.5 % 
(diagnostic delay > 20 years) (p = 0.020, Cochran-Armitage trend test). Furthermore, the 
prevalence of purely inflammatory features decreased with increasing duration of diagnostic 
delay period (p = 0.019). The prevalence of esophageal strictures positively correlated with 
the presence of endoscopic fibrotic features (Spearman’s rho 0.3226, p < 0.001) and 
subepithelial fibrosis (rho 0.1927, p < 0.001). 
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The Prevalence of Strictures at EoE Diagnosis Significantly Correlates with the 
Duration of Diagnostic Delay 
     We evaluated the prevalence of strictures at the time of EoE diagnosis stratified according 
to the length of the diagnostic delay periods. These findings are shown in Table 4. An 
increase in the stricture prevalence was observed over time, such that a group with a 
diagnostic delay of 0 - 2 years had a stricture prevalence of 17.2 %, while a group with 
diagnostic delay of > 20 years exhibited a stricture prevalence of 70.8 %. The Cochran-
Armitage trend test revealed a significant increase in the prevalence of strictures with the 
increasing length of diagnostic delay period (p < 0.001). Figure 3 illustrates the “stricture-
free” survival of the EoE patients over the diagnostic delay period encompassing > 20 years. 
We were also interested if EoE in the group of 60 patients with symptom onset between 0 to 
≤ 20 years of age progressed differently from the disease in the group of 140 patients with 
symptom onset at > 20 years of age with respect to stricture formation. Therefore, we 
performed logistic regression modeling evaluating gender, presence of allergies, length of 
diagnostic delay period, presence of EoE family history, presence of blood eosinophilia, and 
elevated IgE levels as risk factors for the presence of strictures at the time of EoE diagnosis. 
These results are depicted in Supplementary Table 1. We found that the length of 
diagnostic delay was the only factor associated with the presence of strictures at the time of 
EoE diagnosis in the ≤ 20 years of age symptom onset group (OR 1.116, 95% CI 1.041 - 
1.195, p = 0.002) as well as in the group of patients with EoE symptom onset > 20 years of 
age (OR 1.088, 95% CI 1.032 - 1.148, p = 0.002). We conclude that the population with 
symptom onset at ≤ 20 years of age does not seem to be different from the group with EoE 
symptom onset of > 20 years of age regarding stricture formation. 
     We also evaluated whether the relationship between the prevalence of strictures at the 
time of EoE diagnosis and the duration of untreated EoE can also be observed in the 
externally-diagnosed EoE patients, for whom data on the diagnostic delay were available 
(359/460 patients [78.0 %]). We observed the following stricture prevalence at the time of 
diagnosis for each corresponding diagnostic delay period: 18/155 patients (11.6 %) for 
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diagnostic delay period of 0 - 2 years; 8/60 patients (13.3 %) for diagnostic delay period of > 
2 - 5 years; 6/30 patients (20.0 %) for diagnostic delay period of > 5 - 8 years; 13/43 patients 
(30.2 %) for diagnostic delay period of > 8 - 11 years; 4/15 patients (26.7 %) for diagnostic 
delay period of > 11 - 14 years; 6/11 patients (54.5 %) for diagnostic delay period of > 14 - 17 
years; 8/19 patients (42.1 %) for diagnostic delay period of > 17 - 20 years; 9/16 patients 
(56.3 %) for diagnostic delay period of > 20 years. Using the Cochran-Armitage trend test, 
we found that the prevalence of strictures at the time of EoE diagnosis increased with the 
increasing length of diagnostic delay period (p < 0.001) also in the externally diagnosed EoE 
patients. 
 
Risk Factors for Stricture Formation 
     Using logistic regression modeling, we evaluated whether some patients are at higher risk 
than others to develop strictures. The dependent variables for the outcome “presence of 
stricture(s) at the time of EoE diagnosis” are described in the methods section. The results of 
the logistic regression modeling are shown in Supplementary Table 2. Using univariate 
logistic modeling, we found that length of diagnostic delay (OR 1.080 per year, 95% CI 1.040 
- 1.122, p < 0.001) was the only factor significantly associated with the presence of strictures 
at the time of EoE diagnosis. Of note, age at EoE symptom onset was not associated with 
the presence of strictures at the time of EoE diagnosis (OR 0.988, 95% CI 0.969 - 1.006, 
p = 0.195). 
     We hypothesized that persistent inflammatory activity could accelerate stricture formation 
in EoE patients. To evaluate a relationship between peak eosinophil counts in esophageal 
biopsies and stricture formation, we calculated the Spearman’s correlation coefficient. 
However, the presence of strictures at the time of EoE diagnosis correlated neither with the 
proximal (Spearman’s rho 0.048, p = 0.580) nor with the distal peak eosinophil counts 
(Spearman’s rho 0.099, p = 0.248). Of note, tissue eosinophilia at a single time point, such 
as at the time of EoE diagnosis, is not likely to reflect the overall histologic disease activity 
over the entire course of the disease. 
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DISCUSSION 
     Stricture formation is a major complication of EoE. We were able to demonstrate that 
patients are more likely to present with purely inflammatory endoscopic EoE features early in 
the disease course and then progress to develop fibrotic endoscopic features, in addition to 
inflammatory features. Also, the risk of developing esophageal strictures is significantly 
associated with the length of diagnostic delay, a time period from appearance of first 
symptoms to establishment of EoE diagnosis. We further showed that diagnostic delay is 
longest in young patients (median of 10 years in the symptom onset group from 0 to 10 
years) and gradually decreases with age. 
     So far, the natural history of untreated EoE has not been extensively investigated. In a 
first study, published 10 years ago, Straumann et al. examined an adult cohort of 30 EoE 
patients, who were not treated with any anti-inflammatory therapy over a mean time period of 
7.2 years.[7] This study demonstrated that tissue eosinophilia as well as symptoms persisted 
for years and, therefore, provided the first evidence that EoE is a chronic disease. In 
addition, this study showed for the first time that subepithelial fibrosis might develop over 
time. Later on, in studies by Aceves et al. and Mishra et al., it was demonstrated that 
untreated chronic eosinophil-predominant inflammation may lead to esophageal remodeling 
with fibrosis and stricture formation.[18,19] After these initial findings and the work that 
followed, it became evident that EoE should be treated.[8,9,18,19] Due to the rareness of 
purely observational studies, our understanding of the natural history of EoE remains limited. 
     For the purposes of this study, we made use of the EoE patients’ ability to cope for years 
with their symptoms prior to seeking medical attention and subsequent establishment of 
diagnosis. We analyzed the length of this self-reported pre-diagnostic period and various 
clinical characteristics at the time of EoE diagnosis in order to learn more about stricture 
development in the absence of therapeutic interventions. In our cohort, a median diagnostic 
delay of 6 years was observed. This length of diagnostic delay is comparable to the mean 
duration of symptoms before diagnosis of 4 years observed by Kanakala et al. in the United 
Kingdom.[20] We found that the length of diagnostic delay was positively correlated with the 
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prevalence of esophageal strictures. This finding provides evidence that the individual’s 
disease course is a continuum - a march from a disease predominantly inflammatory in 
nature to a disease with endoscopic fibrotic features including strictures in addition to existing 
inflammation. Our findings are comparable to those obtained during a study on a natural 
history of Crohn’s disease conducted by Cosnes et al. The authors found that initially present 
inflammatory uncomplicated disease (defined as absence of strictures and/or fistulas) over 
time evolves into a penetrating and/or stricturing disease.[13] Despite the fact that there are 
many differences between EoE and Crohn’s disease, fibrosis, being a universal repair 
mechanism, is common to these two conditions.[21] 
     We were also interested to identify potential disease, environmental and patient-inherent 
risk factors for stricture formation. Our study demonstrates that the length of diagnostic delay 
is the major risk factor for stricture formation. It is well established that strictures contribute to 
symptom generation as well as occurrence of potentially dangerous food bolus 
impactions.[17,22] 
     In Switzerland, approximately 250 board-certified gastroenterologists, working in 
university hospitals, general hospitals and private practices provide gastroenterological care. 
These physicians are educated in the diagnostic and therapeutic management of EoE 
patients. Furthermore, health insurance in Switzerland is mandatory, and residents have 
easy access to medical care. Nonetheless, despite these favorable conditions for early EoE 
diagnosis, median diagnostic delay observed in this study cohort was 6 years. Analysis 
according to the decade of symptom onset revealed longest diagnostic delays in patients ≤ 
20 years of age. The long diagnostic delay in children/young adults might be related to the 
fact that an upper endoscopy needs to be performed under general anesthesia, and, hence, 
physicians are more reluctant to refer children for endoscopy. In addition, physicians 
perceive dysphagia as an alarm symptom of esophageal cancer in the adult population, 
which leads to a faster referral for upper endoscopy and a shorter diagnostic delay in adults. 
     Our study has several important strengths, but also a number of limitations. It is the first 
long-term study demonstrating that EoE patients are more likely to present with inflammatory 
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esophageal endoscopic features earlier in the disease course and mostly develop fibrotic 
endoscopic features, in addition to inflammatory features, as disease progresses. One major 
limitation of this study is its retrospective design. We tried to minimize the drawbacks 
associated with such study design by using strict inclusion and exclusion criteria, by applying 
the same methodology for the assessment of symptoms, endoscopic and histologic 
abnormalities,[1,16] and by systematic re-evaluation of all raw data. The presence of 
strictures was assessed based on the degree of difficulty with which an endoscope (with 
either 9-mm or 6-mm diameter) could pass through the esophagus. Thus, the presence of 
strictures is likely under-estimated in this study. We neither radiologically measured 
esophageal diameter nor determined the distensibility of the esophagus.[23] Determination of 
the distensibility of the esophagus with the EndoFlip device, as recently described by 
Kwiatek et al., has the potential to detect more subtle esophageal narrowings.[23] Estimation 
of the length of diagnostic delay in our study was based on patient’s reported outcomes, 
which is a subject to a recall bias. While there is consensus among the members of scientific 
community and regulatory agencies that symptoms should be assessed by patients 
themselves [24,25], the extent of correlation between patient-reported outcomes and 
endoscopic and histologic findings has not yet been determined and needs to undergo 
further evaluation.[26-29] We addressed the potential issue of a referral bias by comparing 
the results of time-dependent stricture development in the group of 200 patients diagnosed 
by the senior author (AS) with the group of 460 externally diagnosed EoE patients. Although 
the assessment of endoscopic features at the time of EoE diagnosis was not standardized in 
this external cohort, we found, similarly to the results in the “core” cohort of 200 patients, that 
the prevalence of strictures at the time of EoE diagnosis significantly increased with ongoing 
duration of untreated disease. Therefore, we believe that referral bias did not majorly 
influence our results regarding stricture formation. 
     In conclusion, our analysis of a large group of untreated EoE patients demonstrates that 
the prevalence of strictures is directly correlated with the length of diagnostic delay. In 
addition, EoE patients are more likely to present with inflammatory endoscopic features early 
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in the disease course and mostly develop fibrotic endoscopic features, in addition to the 
inflammatory features, as disease progresses. Measures should be undertaken to reduce the 
diagnostic delay in EoE. 
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FIGURE LEGEND 
 
Figure 1:  Diagnostic delay (time from first symptoms to diagnosis) in relation to age at 
EoE symptom onset (in decades). The horizontal line in the box represents 
the median; the box includes values from the 25th to 75th percentile. The figure 
shows that diagnostic delay is longest in patients with symptom onset ≤ 20 
years of age, and that diagnostic delay gradually decreases with increasing 
age of the patient. 
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Figure 2:  Types of the endoscopic features present at the time of EoE diagnosis 
stratified according to the length of diagnostic delay period. The frequency of 
patients exhibiting purely inflammatory endoscopic features at the time of EoE 
diagnosis decreased with the increasing length of diagnostic delay period, and 
the frequency of patients exhibiting a combination of inflammatory and fibrotic 
endoscopic features increased with increasing length of diagnostic delay 
period. 
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Figure 3:  Percentage of patients without strictures over the diagnostic delay period 
encompassing > 20 years. 
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TABLES 
Table 1: Demographic and disease-specific characteristics of included EoE patients. 
 
Characteristic Frequency  
Number of patients 200 
Males 153 (76.5 %) 
Age at symptom onset (median, IQR) (years) 31, 17 - 44 
Age at EoE diagnosis (median, IQR) (years) 39, 28 - 50 
Diagnostic delay (median, IQR, range) (years) 6, 2 - 12, 0 - 40 
Symptoms leading to EoE diagnosis 
- Dysphagia 
- Chest pain 
- Regurgitations 
- Abdominal pain 
- Vomiting 
- Weight loss 
 
189 (94.5 %) 
71 (35.5 %) 
9 (4.5 %) 
3 (1.5 %) 
2 (1.0 %) 
1 (0.5 %) 
Family history for EoE 24 (12.0 %) 
Concomitant allergies 
- Rhinoconjunctivitis 
- Asthma 
- Neurodermitis 
- Oral allergy syndrome 
- Food allergies 
132 (66.0 %) 
85 (42.5 %) 
74 (37.0 %) 
8 (4.0 %) 
9 (4.5 %) 
41 (20.5 %) 
Endoscopic bolus removal 
- Prior to EoE diagnosis 
- At time of EoE diagnosis 
56 (28.0 %) 
28 (14.0 %) 
28 (14.0 %) 
Concomitant gastroesophageal reflux disease 
- Barrett Esophagus 
23 (11.5 %) 
4 (2.0 %) 
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Table 2: Endoscopic, histologic, and laboratory characteristics of EoE patients at the time of 
diagnosis. 
 
Characteristic Frequency  
Endoscopy 
Strictures 75 (37.5 %) 
Corrugated rings 136 (68 %) 
White exudates 105 (52.5 %) 
Edema 151 (75.5 %) 
Furrows 131 (65.5 %) 
Crêpe-paper esophagus 44 (22 %) 
Histology: median, interquartile range, range or frequency 
Proximal peak eosinophil count 35, 20-61, 0 - 167 
Distal peak eosinophil count 28, 12-65, 0 - 192 
Basal cell hyperplasia 188 (94 %) 
Papillary elongation 192 (96 %) 
Subepithelial fibrosis 
- Absent 
- Mild to moderate 
- Severe 
- No tissue to assess  
 
9 (4.5 %) 
71 (35.5 %) 
18 (9 %) 
102 (51 %) 
Dysplasia 0 
Laboratory markers: median, interquartile range, range or frequency 
Blood eosinophil count (G/L) 0.324, 0.148 - 0.506, 0.0 - 1.214 
Blood eosinophilia (> 0.35 G/L) 58 (29 %) 
IgE (kU/L) 169, 55 - 344, 5 - 2500 
Elevated levels of IgE (> 100 kU/L) 124 (62 %) 
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Table 3: Characterization of esophageal strictures found at the time of EoE diagnosis in 75 EoE 
patients. 
 
Characteristic Frequency or median, interquartile 
range, range  
Number of strictures 
 1 
 2 
 3 
 
64 (85.4 %) 
7 (9.3 %) 
4 (5.3 %) 
Stricture grading* 
 Low grade 
 Intermediate 
 High grade 
 
60 (80 %) 
12 (16 %) 
3 (4 %) 
Stricture length (cm) 2.5, 2 - 4, 0.5 - 10 
Stricture location 
 Proximal esophagus 
 Distal esophagus 
 Proximal and distal esophagus 
 
35 (46.7 %) 
37 (49.3 %) 
3 (4 %) 
 
*The following definitions were applied for the stricture grading: a stricture was classified as low-
grade if it could be passed with a standard endoscope (9 mm outer diameter) with some 
resistance, often inducing lacerations (crêpe-paper esophagus); a stricture was classified as 
intermediate-grade if it could not be passed with a 9-mm outer diameter endoscope, but could 
be passed with a 6-mm outer diameter endoscope; a stricture was classified as high-grade if it 
could not be passed with a 6-mm outer diameter endoscope. 
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Table 4: Prevalence of strictures in patients diagnosed with EoE after a diagnostic delay period 
that ranged from 0 - > 20 years. 
 
Diagnostic delay 
(years) 
Number of 
patients  
Number of 
patients with 
strictures at the 
time of EoE 
diagnosis 
Stricture 
Prevalence 
(%) 
0 - 2 58 10 17.2 
>2 - 5 39 12 30.8 
> 5 - 8 18 7 38.9 
> 8 - 11 29 11 37.9 
> 11 - 14 12 5 41.7 
> 14 - 17 14 9 64.3 
> 17 - 20 6 4 66.7 
> 20 24 17 70.8 
 
The stricture prevalence increases with increasing length of the diagnostic delay period, which 
represents the duration of untreated EoE (Cochran-Armitage trend test, p < 0.001). 
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Supplementary Table 1: Logistic regression modeling evaluating risk factors for the 
presence of strictures at EoE diagnosis stratified according to age at symptom onset. 
Duration of untreated EoE, corresponding to the diagnostic delay, was the only risk factor in 
both groups associated with presence of strictures at the time of EoE diagnosis.  
 
Symptom onset 
1 - ≤ 20 years 
Symptom onset 
> 20 years 
Univariate model  Univariate model 
Candidate  
Risk factor for 
presence of stricture at 
the time of EoE 
diagnosis OR, 95% CI p-value OR, 95% CI p-value 
Gender 
Male 
Female  
1.190 
0.336-4.213 
0.787 0.780 
0.332-1.834 
0.570 
Allergies 
Present 
Absent 
0.455 
0.117-1.764 
0.255 1.455 
0.609-3.469 
0.398 
Diagnostic delay (years) 1.116 
1.041-1.195 
0.002 1.088 
1.032-1.148 
0.002 
Family history of EoE 
Present 
Absent 
0.677 
0.176-2.604 
0.570 1.101 
0.294-4.123 
0.887 
Blood eosinophilia 
Present 
Absent 
1.667 
0.251-11.071 
0.597 0.938 
0.297-2.962 
0.912 
Elevated IgE levels 
Present 
Absent 
1.678 
0.570-4.936 
0.347 1.773 
0.533-5.898 
0.351 
 
Logistic regression modeling with the outcome “presence of stricture at the time of EoE 
diagnosis”. Univariate logistic regression modeling was performed. The Odds Ratio (OR) is 
computed on the underlined outcome of the dependent variable of the logistic regression 
model. The variable “diagnostic delay” is entered as continuous variable. 
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Supplementary Table 2: Analysis of potential risk factors for stricture development in EoE 
patients. 
 
Univariate Model Candidate  
Risk Factor OR, 95% CI p-value 
Gender: 
Male 
Female  
0.953 
0.476-1.909 
0.892 
Allergies 
Present 
Absent 
0.968 
0.474-1.978 
0.928 
Diagnostic delay (years) 1.080 
1.040-1.122 
<0.001 
Age at onset of EoE symptoms 
(years) 
0.988 
0.969-1.006 
0.195 
Family history of EoE 
Present 
Absent 
0.825 
0.332-2.049 
0.678 
Blood eosinophilia 
Present 
Absent 
1.111 
0.421-2.935 
0.832 
Elevated IgE levels 
Present 
Absent 
1.678 
0.57-4.936 
0.347 
Peak eosinophil count 
≥ 100 per hpf 
< 100 per hpf 
1.911 
0.796-4.586 
0.147 
 
Logistic regression modeling with the outcome “presence of stricture at the time of EoE 
diagnosis”. Univariate logistic regression modeling was performed. The Odds Ratio (OR) is 
computed on the underlined outcome of the dependent variable of the logistic regression 
model.  
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